This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

Media Center

Browse our most recent press releases, announcements, and mentions of PATH in the news.

Contact Us

Director of Marketing & Communications:
Lindsay Bosslet, MPH

Phone: 206.285.3500

Fax: 206.285.6619

Email: media@path.org

Recent Press Coverage

  1. New formulas and off-grid approaches could help mRNA vaccines get to more places around the world. PATH’s vaccine vial monitors are highlighted, and Pat Lennon explains the importance of thermostable vaccines in extending reach and access.
    Published: March 2021
  2. Since the start of COVID-19, the Global Financing Facility for Women, Children, and Adolescents (GFF) has been sounding the alarm about the pandemic’s toll on women and children. PATH’s Pauline Irungu speaks to the impact in Kenya and the importance of en
    Published: March 2021
  3. Before COVID-19, the public health community in India was focused on eliminating tuberculosis (TB). PATH’s Shibu Vijayan explains how the COVID-19 pandemic sidetracked some TB efforts—and explores what it will take to get back on track.
    Published: February 2021
  4. Johnson & Johnson’s one-shot COVID-19 vaccine may aid difficult-to-reach populations. PATH’s Dr. David Fleming discusses possible applications of the new vaccine, and the importance of national guidelines.
    Published: February 2021
Load more

PATH Newsroom

831 Items
831 Items
831 Items
    Date
  1. PATH’s board of directors has voted to appoint Dr. Fredrick Namenya Were as its new member.Dr. Were brings extensive experience in maternal and newborn health, child nutrition, health services and immunization.
    Published: March 2021
    Type: Press Release
  2. Published: March 2021
    Type: Press Release
  3. PATH and The University of Queensland (UQ)’s Protein Expression Facility have collaborated to develop and bring to market custom proteins to support the development and evaluation of point-of-care diagnostics for malaria.
    Published: March 2021
    Type: Press Release
  4. Published: January 2021
    Type: Press Release
  5. Published: January 2021
    Type: Press Release
Load more